Feedback / Questions
ADRX-0706 - Adcentrx Therap
https://www.prnewswire.com/news-releases/adcentrx-therapeutics-announces-first-patient-dosed-in-the-phase-1ab-study-of-adrx-0706-a-novel-adc-targeting-nectin-4-for-the-treatment-of-advanced-solid-tumors-301939776.html
Sep 27, 2023
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next